See also this year's filing and all EDGAR filings for this company.
PDF Report 0001582313_2021_Xenon_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001582313, Xenon Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 181,783,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,554,000 |
| 3 | remainder_Assets | 3,849,000 |
| 4 | LiabilitiesCurrent | 14,781,000 |
| 5 | LiabilitiesNoncurrent | 3,050,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,734,283 |
| 9 | ResearchAndDevelopmentExpense | 61,792,609 |
| 10 | remainder_Expenses | 575,723 |
| 11 | remainder_Revenues | 32,275,596 |
| 12 | remainder_NetIncome | 2,668,874 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 189,186,000 |
| 1 | Liabilities | 17,831,000 |
| 2 | Expenses | 76,102,615 |
| 3 | Revenues | 32,275,596 |
| 4 | StockholdersEquity | 171,355,000 |
| 5 | NetIncome | -41,158,145 |
| 6 | ComprehensiveNetIncome | -41,158,145 |
| 7 | BaseVar | 159,032,042 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.21 |
| 9 | EconomicCapitalRatio | 3.83 |
Edgar->Model Mapping
Feature Distribution
Change over Time
